| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 9 Feb 2026 | 31 Jan 2026 |
| Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve 1. To consider and approve the date of holding EOGM for regularising the appointment of Mr. Shailendra Pathak as the Whole Time Director of the Company and fixing his role obligations and responsibilities and remuneration and for the appointment of Mrs. Neha Sarda as an Independent Director and for approval for material Related Party Transactions with M/s. Aminova Infusions P. Ltd. where Mr. Shailendra Pathak is a director holding 50% equity. 2. To consider and approve the Unaudited Quarterly Financial Results for the quarter ended 31st December 2025 3. To take on record the Limited Review Report by the Auditors for the quarter ended 31st December 2025 OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on: 09/02/2026) | ||
| Board Meeting | 3 Jan 2026 | 23 Dec 2025 |
| Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/01/2026 inter alia to consider and approve 1. To consider and approve the Appointment of Shailendra Pathak as an Additional Director subject to approval of shareholders in general meeting. 2. To consider and approve the Appointment of Mrs. Neha Sharda as an Independent Director subject to approval of shareholders in general meeting. 3. To consider and approve related party transaction with Aminova Infusions P. Ltd. subject to approval of shareholders in general meeting. 4. To consider and approve the resignation of Mrs. Neha Sharma from post of Company Secretary. 5. To consider and approve appointment of Mr. Kamlesh Gupta as the Company Secretary. 6. To consider and approve the date of holding EOGM. 7. Any other matter with the permission of the Chair. OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on 03.01.2026) | ||
| Board Meeting | 13 Nov 2025 | 5 Nov 2025 |
| Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve consider and approve the unaudited financial results for the quarter ended 30th September 2025 OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on 13.11.2025) | ||
| Board Meeting | 2 Sep 2025 | 25 Aug 2025 |
| Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2025 inter alia to consider and approve consideration and approval of the Board report and other matters related to 32nd Annual General Meeting of the Company. OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on:02.09.2025) | ||
| Board Meeting | 7 Aug 2025 | 29 Jul 2025 |
| Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 inter alia to consider and approve the unaudited financial results for the quarter ended 30th June 2025. OUTCOME OF BOARD MEETING UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE, 2025 (As Per BSE Announcement Dated on:07.08.2025) | ||
| Board Meeting | 30 May 2025 | 19 May 2025 |
| Audited Results - Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31ST MARCH 2025. OUTCOME OF BOARD MEETING (As Per BSE Announcement Dated on: 30/05/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
